Page 28 - Arix Bioscience News Today

Arix Bioscience PLC: Autolus provides business outlook for 2021 and 2022 DJ Autolus provides business outlook for 2021 and 2022 Arix Bioscience PLC (ARIX) Autolus provides business outlook for 2021 and 2022 06-Jan-2021 / 10:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Arix Bioscience plc Autolus provides business outlook for 2021 and 2022 LO...

(2) DJ Imara reports Phase 2a clinical trial results of IMR-687 in adult patients with sickle cell disease Arix Bioscience PLC (ARIX) Imara reports Phase 2a clinical trial results of IMR-687 in adult patients with sickle cell disease 06-Jan-2021 / 14:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Arix Bioscience plc Imara reports Phase 2a clinical trial results of IMR-687 in adu...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site, we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, as-is, and you use it at your own risk. The contents of all Chat messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its aff...

Arix Bioscience PLC: Completion of sale of VelosBio DJ Completion of sale of VelosBio Arix Bioscience PLC (ARIX) Completion of sale of VelosBio 18-Dec-2020 / 08:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Arix Bioscience plc Completion of sale of VelosBio LONDON, 18 December 2020: Arix Bioscience plc ("Arix", LSE: ARIX), a global ...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...